Metabolites as regulators of insulin sensitivity and metabolism
Q Yang, A Vijayakumar, BB Kahn - Nature reviews Molecular cell …, 2018 - nature.com
The cause of insulin resistance in obesity and type 2 diabetes mellitus (T2DM) is not limited
to impaired insulin signalling but also involves the complex interplay of multiple metabolic …
to impaired insulin signalling but also involves the complex interplay of multiple metabolic …
Epithelial cells and inflammation in pulmonary wound repair
A Croasdell Lucchini, NN Gachanja, AG Rossi… - Cells, 2021 - mdpi.com
Respiratory diseases are frequently characterised by epithelial injury, airway inflammation,
defective tissue repair, and airway remodelling. This may occur in a subacute or chronic …
defective tissue repair, and airway remodelling. This may occur in a subacute or chronic …
Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4
X Fang, J Abbott, L Cheng, JK Colby… - The Journal of …, 2015 - journals.aai.org
Previous studies demonstrated that bone marrow–derived mesenchymal stem (stromal)
cells (MSCs) reduce the severity of acute lung injury in animal models and in an ex vivo …
cells (MSCs) reduce the severity of acute lung injury in animal models and in an ex vivo …
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
C Rey, A Nadjar, B Buaud, C Vaysse, A Aubert… - Brain, behavior, and …, 2016 - Elsevier
Sustained inflammation in the brain together with microglia activation can lead to neuronal
damage. Hence limiting brain inflammation and activation of microglia is a real therapeutic …
damage. Hence limiting brain inflammation and activation of microglia is a real therapeutic …
Roles of resolvins in chronic inflammatory response
C Liu, D Fan, Q Lei, A Lu, X He - International journal of molecular …, 2022 - mdpi.com
An inflammatory response is beneficial to the organism, while an excessive uncontrolled
inflammatory response can lead to the nonspecific killing of tissue cells. Therefore …
inflammatory response can lead to the nonspecific killing of tissue cells. Therefore …
Specialized proresolving mediators in innate and adaptive immune responses in airway diseases
N Krishnamoorthy, REE Abdulnour… - Physiological …, 2018 - journals.physiology.org
Airborne pathogens and environmental stimuli evoke immune responses in the lung. It is
critical to health that these responses be controlled to prevent tissue damage and the …
critical to health that these responses be controlled to prevent tissue damage and the …
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm
CH Lee - Archives of pharmacal research, 2021 - Springer
Unexpected viral infections outbreaks, significantly affect human health, leading to
increased mortality and life disruption. Among them is the severe acute respiratory …
increased mortality and life disruption. Among them is the severe acute respiratory …
Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis
JW Kang, SM Lee - Biochimica et Biophysica Acta (BBA)-Molecular and …, 2016 - Elsevier
Resolution of inflammation is an active process involving a novel category of lipid factors
known as specialized pro-resolving lipid mediators, which includes Resolvin D1 (RvD1) …
known as specialized pro-resolving lipid mediators, which includes Resolvin D1 (RvD1) …
[HTML][HTML] Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of …
Bacterial pneumonia is a leading cause of morbidity and mortality worldwide. Host
responses to contain infection and mitigate pathogen-mediated lung inflammation are …
responses to contain infection and mitigate pathogen-mediated lung inflammation are …
[HTML][HTML] Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli–driven acute inflammation
While the treatment of inflammatory disorders is generally based on inhibiting factors that
drive onset of inflammation, these therapies can compromise healing (NSAIDs) or dampen …
drive onset of inflammation, these therapies can compromise healing (NSAIDs) or dampen …